[1] Wang C, Horby PW, Hayden FG, Gao GF (2020) A novel coronavirus outbreak of global health concern. Lancet 395 (10223):470-473
[2] Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, Hengartner N, Giorgi EE, Bhattacharya T, Foley B, Hastie KM, Parker MD, Partridge DG, Evans CM, Freeman TM, de Silva TI, Sheffield COVID-19 Genomics Group, McDanal C, Perez LG, Tang H, Moon-Walker A, Whelan SP, LaBranche CC, Saphire EO, Montefiori DC ( 2020) Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. Cell 182 (4):812-827.e819
[3] Rambaut A, Loman N, Pybus O, Barclay W, Barrett J, Carabelli A, Connor T, Peacock T, Robertson LD, Volz E, UK C-GC (2020) Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations. Virological.org. Posted December 16, 2020. Accessed January 19, 2021. https://virological. org/t/preliminary-genomic-characterisation-of-an-emergent-sars-cov-2-lineage-in-the-uk-defined- by-a-novel-set-of-spike-mutations/563.
[4] Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J, Doolabh D, Pillay S, San EJ, Msomi N, Mlisana K, Gottberg AV, Walaza S, Allam M, Ismail A, Mohale T, Glass AJ, Engelbrecht S, Zyl GV, Preiser W, Petruccione F, Sigal A, Hardie D, Marais G, Hsiao M, Korsman S, Davies MA, Tyers L, Mudau I, York D, Maslo C, Goedhals D, Abrahams S, Laguda-Akingba O, Alisoltani-Dehkordi A, Godzik A, Wibmer CK, Sewell BT, Lourenço J, Alcantara LCJ, Pond SLK, Weaver S, Martin D, Lessells RJ, Bhiman JN, Williamson C, de Oliveira T (2020) Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa.Preprint at medRxiv.
[5] Kirby T (2021) New variant of SARS-CoV-2 in UK causes surge of COVID-19. Lancet Respir Med S2213-2600 (21):00005-00009
[6] Callaway E (2021) Could new COVID variants undermine vaccines? Labs scramble to find out. Nature 589 (7841):177-178
[7] Xie X, Zou J, Fontes-Garfias CR, Xia H, Swanson KA, Cutler M, Cooper D, Menachery VD, Weaver S, Dormitzer PR, Shi PY (2021) Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera. bioRxiv. .
[8] Resende PC, Bezerra JF, de Vasconcelos RHT, Arantes I, Appolinario L, Mendonça AC, Paixao AC, Rodrigues ACD, Silva T, Rocha AS, Pauvolid-Corrêa A, Motta FC, Teixeira DLF, de Oliveira Carneiro TF, Neto FPF, Herbster ID, Leite AB, Riediger IN, Debur MDC, Naveca FG, Almeida W, Livorati M, Bello G, Siqueira MM (2021) Spike E484K mutation in the first SARS-CoV-2 reinfection case confirmed in Brazil, 2020. Virological.org. Posted January 10, 2021 Accessed January 20, 2021. https://virological.org/t/spike-e484k-mutation-in-the-first-sars-cov-2-reinfection-case-confirmed-in-brazil-2020/584.
[9] Overbaugh J (2020) Understanding protection from SARS-CoV-2 by studying reinfection. Nat Med 26 (11):1680-1681
[10] Batra R, Olivieri LG, Rubin D, Vallari A, Pearce S, Olivo A, Prostko J, Nebbia G, Douthwaite S, Rodgers M, Cloherty G (2020) A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay. J Clin Virol 132:104645
[11] Lemriss S, Souiri A, Amar N, Lemzaoui N, Mestoui O, Labioui M, Ouaariba N, Jibjibe A, Yartaoui M, Chahmi M, El Rhouila M, Sellak S, Kandoussi N, El Kabbaj S (2020) Complete Genome Sequence of a 2019 Novel Coronavirus (SARS-CoV-2) Strain Causing a COVID-19 Case in Morocco. Microbiol Resour Announc 9 (27 ):e00633-00620
[12] Jouali F, Marchoudi N, El Ansari FZ, Kasmi Y, Chenaoui M, El Aliani A, Azami N, Loukman S, Ennaji MM, Benhida R, Fekkak J (2020) SARS-CoV-2 Genome Sequence from Morocco, Obtained Using Ion AmpliSeq Technology. Microbiol Resour Announc 9 (31):e00690-00620
[13] Laamarti M, Chemao-Elfihri MW, Kartti S, Laamarti R, Allam L, Ouadghiri M, Smyej I, Rahoui J, Benrahma H, Diawara I, Alouane T, Essabbar A, Siah S, Karra M, El Hafidi N, El Jaoudi R, Sbabou L, Nejjari C, Amzazi S, Mentag R, Belyamani L, Ibrahimi A (2020) Genome Sequences of Six SARS-CoV-2 Strains Isolated in Morocco, Obtained Using Oxford Nanopore MinION Technology. Microbiol Resour Announc 9 (32)::e00767-00720
[14] Song S, Ma L, Zou D, Tian D, Li C, Zhu J, Chen M, Wang A, Ma Y, Li M, Teng X, Cui Y, Duan G, Zhang M, Jin T, Shi C, Du Z, Zhang Y, Liu C, Li R, Zeng J, Hao L, Jiang S, Chen H, Han D, Xiao J, Zhang Z, Zhao W, Xue Y, Bao Y (2020) The global landscape of SARS-CoV-2 genomes, variants, and haplotypes in 2019nCoVR. bioRxiv:2020.2008.2030.273235
[15] Fournier PE, Colson P, Levasseur A, Devaux C, Gautret P, Bedotto M, Delerce J, Brechard L, Pinault L, Lagier JC, Fenollar F, Raoult D (2021) Emergence and outcome of the SARS-CoV-2 “Marseille-4” variant. Preprint IHU doi: https://doi.org/10.35081/xcrm-6t77.
[16] Colson P, Levasseur A, Gautret P, Fenollar F, Thuan Hoang V, Delerce J, Bitam I, Saile R, Maaloum M, Padane A, Bedotto M, Brechard L, Bossi V, Khedher MB, Chaudet H, Million M, Tissot-Dupont H, Lagier JC, Mboup S, Fournier PE, Raoult D (2021 ) Introduction into the Marseille geographical area of a mild SARS-CoV-2 variant originating from sub-Saharan Africa: an investigational study. Travel Med Infect Dis 101980
[17] To KK, Hung IF, Chan KH, Yuan S, To WK, Tsang DN, Cheng VC, Chen Z, Kok KH, Yuen KY (2020) Serum antibody profile of a patient with COVID-19 reinfection. Clin Infect Dis ciaa1368
[18] Colson P, Finaud M, Levy N, Lagier JC, Raoult D (2020) Evidence of SARS-CoV-2 re-infection with a different genotype. J Infect S0163-4453 (20):30706-30704
[19] Colson P, Levasseur A, Delerce J, Chaudet H, Bossi V, Ben Khedher M, Fournier PE, Lagier JC, Raoult D (2020) Dramatic increase in the SARS-CoV-2 mutation rate and low mortality rate during the second epidemic in summer in Marseille. Preprint IHU 2020;doi:https://doi.org/10.35088/68c3-ew82 .
[20] Tillett RL, Sevinsky JR, Hartley PD, Kerwin H, Crawford N, Gorzalski A, Laverdure C, Verma SC, Rossetto CC, Jackson D, Farrell MJ, Van Hooser S, Pandori M (2021) Genomic evidence for reinfection with SARS-CoV-2: a case study. Lancet Infect Dis 21 (1):52-58
[21] Deng W, Bao L, Liu J, Xiao C, Liu J, Xue J, Lv Q, Qi F, Gao H, Yu P, Xu Y, Qu Y, Li F, Xiang Z, Yu H, Gong S, Liu M, Wang G, Wang S, Song Z, Liu Y, Zhao W, Han Y, Zhao L, Liu X, Wei Q, Qin C (2020) Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques. Science 369 (6505):818-823
[22] Klein SL, Pekosz A, Park HS, Ursin RL, Shapiro JR, Benner SE, Littlefield K, Kumar S, Naik HM, Betenbaugh MJ, Shrestha R, Wu AA, Hughes RM, Burgess I, Caturegli P, Laeyendecker O, Quinn TC, Sullivan D, Shoham S, Redd AD, Bloch EM, Casadevall A, Tobian AA (2020) Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population. J Clin Invest 130 (11):6141-6150
[23] Zhang B, Zhou X, Zhu C, Song Y, Feng F, Qiu Y, Feng J, Jia Q, Song Q, Zhu B, Wang J (2020) Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19. Front Mol Biosci 7:157
[24] Scepanovic P, Alanio C, Hammer C, Hodel F, Bergstedt J, Patin E, Thorball CW, Chaturvedi N, Charbit B, Abel L, Quintana-Murci L, Duffy D, Albert ML, Fellay J, Milieu Intérieur Consortium (2018) Human genetic variants and age are the strongest predictors of humoral immune responses to common pathogens and vaccines. Genome Med 10 (1):59